Nantahala Capital Management, LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$1.7B
Holdings
115
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (115 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | SCTLSOCIETAL CDMO INC | 1,214,706 | $425.8B | 25481.86% | |
| 102 | SRTSSENSUS HEALTHCARE INC | 176,750 | $417.1B | 24965.71% | |
| 103 | —GAMIDA CELL LTD | 800,000 | $330.2B | 19760.45% | |
| 104 | APSGBPAPTOSE BIOSCIENCES INC | 120,132 | $305.1B | 18262.68% | |
| 105 | LADRLADDER CAP CORP | 25,631 | $295.0B | 17656.86% | |
| 106 | LUCDLUCID DIAGNOSTICS INC | 149,698 | $211.1B | 12633.02% | |
| 107 | TACTTRANSACT TECHNOLOGIES INC | 28,127 | $196.3B | 11750.33% | |
| 108 | XGNEXAGEN INC | 97,124 | $193.3B | 11567.85% | |
| 109 | —BM TECHNOLOGIES INC | 76,034 | $155.9B | 9329.00% | |
| 110 | RFLRAFAEL HLDGS INC | 72,678 | $133.0B | 7960.26% | |
| 111 | CUECUE BIOPHARMA INC | 26,692 | $70.5B | 4217.53% | |
| 112 | MBAICHECK CAP LTD | 33,400 | $69.5B | 4157.98% | |
| 113 | GFAIGUARDFORCE AI CO LTD | 154,205 | $26.2B | 1569.90% | |
| 114 | TCBWFTC BIOPHARM HOLDINGS PLC | 235,294 | $7.6B | 457.68% | |
| 115 | DMPIEURKINTARA THERAPEUTICS INC | 22,021 | $3.7B | 223.54% |
PreviousPage 2 of 2